|

Empagliflozin Clinical Trials

17 actively recruiting trials across 9 locations

No change since May 2026

Also known as: Jardiance, jardiance

Pipeline

Early 1: 1Phase 2: 3Phase 3: 8Phase 4: 4Phase 1/2: 1

Top Sponsors

  • Boehringer Ingelheim4
  • VA Office of Research and Development2
  • EMS2
  • University of Minnesota1
  • University of Alberta1

Indications

Other7 trials

Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Phase 4
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Phase 3
Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
Phase 3
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Phase 2
Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
Phase 3
Feasibility Trial for a Right Ventricular Failure Platform Trial
Phase 2
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Phase 4

Mobile, Alabama2 trials

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Alliance for Multispecialty Research, LLC

Phase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Diagnostic and Medical Clinic

Phase 3

Anniston, Alabama1 trial

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Pinnacle Research Group, LLC

Phase 3

Fairhope, Alabama1 trial

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATION-HF)

CON-10004 Fairhope, AL Investigational Site

Phase 3

Huntsville, Alabama1 trial

EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Apogee Clinical Research

Phase 3

Duarte, California1 trial

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

City of Hope

Phase 1/2

Palo Alto, California1 trial

Randomized Trial of SGLT2i in Heart Transplant Recipients

VA Palo Alto Health Care System, Palo Alto, CA

Phase 4

Hines, Illinois1 trial

Empagliflozin Treatment in Kidney Transplant Recipients

Edward Hines Jr. VA Hospital, Hines, IL

Phase 4

Minneapolis, Minnesota1 trial

Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure

University of Minnesota

Early 1

New York, New York1 trial

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

NYU Langone Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.